trial · primary record
Steroids therapy
Vestibular Schwannoma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 364 |
| Primary completion | 2028-03-30 |
| Primary endpoint | Good facial nerve function (House-Brackmann grade I or II) at 90 days after surgery |
| Registry ID | NCT07116811 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:12.387Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07116811
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.